In this article, we detail the experience with immune checkpoint inhibitors in patients with autoimmune disease.
Daniel Y. Wang, MD
Advertisement
Articles by Daniel Y. Wang, MD
In view of the potential for durable responses with immunotherapy, it will be important to identify the most effective and least toxic regimens for individual patients.
Advertisement
Latest Updated Articles
- Combination Immunotherapy: An Emerging Paradigm in Cancer Therapeutics
Published: December 15th 2015 | Updated:
Immune Checkpoint Inhibitor Therapy in Patients With Autoimmune DiseasePublished: April 15th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer
2
Nivolumab/Ipilimumab Improves Real-World Melanoma Outcomes Vs Pembrolizumab
3
Neoadjuvant Cemiplimab/SBRT Yields Improved DFS in Resectable HCC
4
Novel Anti-CD5 Therapy Earns FDA RMAT Designation in T-Cell Lymphoma
5
